NU-Hope Laboratories Inc Pacoima, CA - 91331

NU-Hope Laboratories Inc is categorized under Colostomy Appliances in Pacoima, CA and active since 1959.

NU-Hope Laboratories Inc was established in 1959, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Colostomy Appliances business, which does work in the B2B market, and is classified as a Colostomy Appliances, under code number 3391120 by the NAICS.

If you are seeking more information, feel free to contact Brad Galindo, President at the company’s single location by writing to 12640 Branford St, Pacoima, California CA 91331 or by phoning (818) 899-7711. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: NU-Hope Laboratories Inc
Contact Person: Brad Galindo, President
Address: 12640 Branford St, Pacoima, California 91331
Phone Number: (818) 899-7711
Website Address: nu-hope.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 1959
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Colostomy Appliances
SIC Code: 3842
NAICS Code: 3391120
Share This Business:

NU-Hope Laboratories Inc was started in 1959 to provide professional Colostomy Appliances under the SIC code 3842 and NAICS code 3391120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Brad Galindo, President for inquiries that concern NU-Hope Laboratories Inc by calling the company number (818) 899-7711, as your correspondence is most welcome. Additionally, the physical location of the single location of NU-Hope Laboratories Inc can be found at the coordinates 34.24388,-118.40902 as well as the street address 12640 Branford St in Pacoima, California 91331.

For its online presence, you may visit NU-Hope Laboratories Inc’s website at nu-hope.com and engage with its social media outlets through on Twitter and on Facebook.